SG11201505227YA - A method for predicting the risk of getting cancer or diagnosing cancer in a subject - Google Patents
A method for predicting the risk of getting cancer or diagnosing cancer in a subjectInfo
- Publication number
- SG11201505227YA SG11201505227YA SG11201505227YA SG11201505227YA SG11201505227YA SG 11201505227Y A SG11201505227Y A SG 11201505227YA SG 11201505227Y A SG11201505227Y A SG 11201505227YA SG 11201505227Y A SG11201505227Y A SG 11201505227YA SG 11201505227Y A SG11201505227Y A SG 11201505227YA
- Authority
- SG
- Singapore
- Prior art keywords
- cancer
- predicting
- risk
- subject
- getting
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/62—Insulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- G01N2333/70—Enkephalins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13150564 | 2013-01-08 | ||
| PCT/EP2014/050144 WO2014108397A1 (en) | 2013-01-08 | 2014-01-07 | A method for predicting the risk of getting cancer or diagnosing cancer in a subject |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201505227YA true SG11201505227YA (en) | 2015-08-28 |
Family
ID=47469833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201505227YA SG11201505227YA (en) | 2013-01-08 | 2014-01-07 | A method for predicting the risk of getting cancer or diagnosing cancer in a subject |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10605812B2 (zh) |
| EP (1) | EP2943792B1 (zh) |
| JP (1) | JP6317763B2 (zh) |
| CN (2) | CN104937419B (zh) |
| CA (1) | CA2897245A1 (zh) |
| ES (1) | ES2710974T3 (zh) |
| HK (1) | HK1215301A1 (zh) |
| RU (1) | RU2701730C2 (zh) |
| SG (1) | SG11201505227YA (zh) |
| TR (1) | TR201901828T4 (zh) |
| WO (1) | WO2014108397A1 (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7271442B2 (ja) * | 2017-05-30 | 2023-05-11 | シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング | 腎機能を診断またはモニターする方法、または腎機能障害を診断することを補助する方法 |
| US20200124605A1 (en) * | 2017-06-08 | 2020-04-23 | University Of Miyazaki | Method for detection of lung cancer |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8613431D0 (en) * | 1986-06-03 | 1986-07-09 | Medical Res Council | Human tachykinins |
| AU634716B2 (en) | 1988-08-01 | 1993-03-04 | Ciba Corning Diagnostics Corp. | Method for detection of an analyte using acridinium esters and liposomes |
| US5430047A (en) * | 1994-04-07 | 1995-07-04 | Warner-Lambert Company | Neurotensin antagonists |
| CN1311208A (zh) * | 2000-03-02 | 2001-09-05 | 上海博德基因开发有限公司 | 一种新的多肽——人beta－前速激肽原9和编码这种多肽的多核苷酸 |
| IL162733A0 (en) * | 2002-01-31 | 2005-11-20 | Hoffmann La Roche | Genetic polymorphisms in the preprotachykinin gene |
| US7485298B2 (en) * | 2002-05-23 | 2009-02-03 | Michael Powell | Diagnosis and treatment of human dormancy-related sequellae |
| US20050186577A1 (en) * | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| ES2524309T3 (es) * | 2004-04-20 | 2014-12-05 | Sphingotec Gmbh | Utilización de precursores de taquicininas y/o de sus fragmentos en diagnóstico médico |
| EP2293079B1 (en) * | 2004-05-13 | 2013-08-14 | B.R.A.H.M.S GmbH | Use of precursors of enkephalins and/or their fragments in medical diagnostics |
| DE102005003687A1 (de) * | 2005-01-26 | 2006-07-27 | Sphingo Tec Gmbh | Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation |
| JP5298266B2 (ja) * | 2006-03-31 | 2013-09-25 | 静岡県 | 小細胞肺癌の判定用キット |
| MY150234A (en) * | 2007-06-29 | 2013-12-31 | Ahn Gook Pharmaceutical Company Ltd | Predictive markers for ovarian cancer |
| JPWO2009044561A1 (ja) * | 2007-10-03 | 2011-02-03 | 静岡県 | 抗ｐｒｏＮＴ／ＮＭＮモノクローナル抗体 |
| EP2217728A4 (en) * | 2007-11-30 | 2011-01-05 | Genomictree Inc | KIT AND DIAGNOSTIC CHIP FOR BLADDER CANCER USING A SPECIFIC METHYLATION MARKER GENE FOR BLADDER CANCER |
| CN115598345A (zh) * | 2008-09-05 | 2023-01-13 | A&G 药品公司（Us） | 诊断癌症和确定癌症患者的总体生存和无病生存的方法 |
| JP5753159B2 (ja) * | 2009-05-05 | 2015-07-22 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 内皮性機能／機能不全に関連した疾患に罹患している患者の血管作動性ホルモンに基づいた層化 |
| EP2464365A2 (en) * | 2009-08-14 | 2012-06-20 | Allergan, Inc. | Methods of treating cancer using tachykinin retargeted endopeptidases |
| CN102139107B (zh) * | 2011-03-23 | 2012-10-03 | 浙江理工大学 | 神经激肽受体拮抗剂在制备抗癌药物中的用途 |
| EP2533052A1 (en) * | 2011-06-07 | 2012-12-12 | B.R.A.H.M.S GmbH | Diagnostic use of proSomatostatin |
| EP2904398B1 (en) * | 2012-10-02 | 2018-04-11 | SphingoTec GmbH | A method for predicting the risk of getting cancer in a female subject |
-
2014
- 2014-01-07 EP EP14700091.3A patent/EP2943792B1/en active Active
- 2014-01-07 SG SG11201505227YA patent/SG11201505227YA/en unknown
- 2014-01-07 CN CN201480004101.4A patent/CN104937419B/zh active Active
- 2014-01-07 ES ES14700091T patent/ES2710974T3/es active Active
- 2014-01-07 JP JP2015551195A patent/JP6317763B2/ja active Active
- 2014-01-07 TR TR2019/01828T patent/TR201901828T4/tr unknown
- 2014-01-07 CA CA2897245A patent/CA2897245A1/en not_active Abandoned
- 2014-01-07 CN CN201810791338.1A patent/CN109116025A/zh active Pending
- 2014-01-07 RU RU2015133019A patent/RU2701730C2/ru active
- 2014-01-07 WO PCT/EP2014/050144 patent/WO2014108397A1/en active Application Filing
- 2014-01-07 US US14/759,724 patent/US10605812B2/en active Active
-
2016
- 2016-03-21 HK HK16103236.0A patent/HK1215301A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2015133019A (ru) | 2017-02-15 |
| EP2943792B1 (en) | 2018-11-14 |
| TR201901828T4 (tr) | 2019-03-21 |
| WO2014108397A4 (en) | 2014-10-02 |
| EP2943792A1 (en) | 2015-11-18 |
| US20150346207A1 (en) | 2015-12-03 |
| US10605812B2 (en) | 2020-03-31 |
| CA2897245A1 (en) | 2014-07-17 |
| CN109116025A (zh) | 2019-01-01 |
| HK1215301A1 (zh) | 2016-08-19 |
| JP6317763B2 (ja) | 2018-04-25 |
| CN104937419B (zh) | 2018-08-10 |
| ES2710974T3 (es) | 2019-04-29 |
| WO2014108397A1 (en) | 2014-07-17 |
| RU2701730C2 (ru) | 2019-10-01 |
| CN104937419A (zh) | 2015-09-23 |
| JP2016505137A (ja) | 2016-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1226484A1 (zh) | 預測出現主要不良心臟事件的風險的方法 | |
| PT2976013T (pt) | Métodos para avaliação de eritema | |
| EP2962268A4 (en) | SYSTEMS AND METHODS FOR ENHANCING CLINICAL DOCUMENTATION | |
| EP2972308A4 (en) | BIOMARKERS AND METHOD FOR PREDICTING AN EARLY BIRTH | |
| HK1211719A1 (zh) | 顧客數據分析/驗證系統 | |
| EP2972393A4 (en) | BIOMARKERS AND METHOD FOR PREDICTING PREECLAMPSIA | |
| LU92173B1 (en) | Distance determination method | |
| HK1209799A1 (zh) | 種無創癌症檢測方法及其試劑盒 | |
| HK1216546A1 (zh) | 評估 風險的方法 | |
| GB201516410D0 (en) | Tool for measuring wellbore geometry | |
| SG11201601288RA (en) | Integrated hydrocarbon analysis | |
| ZA201600963B (en) | Methods and kits for predicting the risk of having a cardiovascular disease or event | |
| HK1216779A1 (zh) | 用於癌症治療的預測性生物標記物 | |
| EP2948769A4 (en) | BLOOD PLATE BIOMARKERS IN CANCER DIAGNOSIS | |
| IL244632A0 (en) | Cancer biomarker and diagnostics | |
| GB201315024D0 (en) | Lubricant analysis | |
| GB201304507D0 (en) | Ultrasonic Inspection Method | |
| HK1212762A1 (zh) | 預測女性對象患癌症風險或診斷其癌症的方法 | |
| GB2535065B (en) | Method for preprocessing metallic magnesium | |
| EP2948903A4 (en) | MODELING WORKFLOW GUIDED BY ASSETS | |
| GB201316752D0 (en) | Methods for determining temperature or temperature | |
| HK1215301A1 (zh) | 預測受試者患癌症的風險或診斷癌症的方法 | |
| PT2821771T (pt) | Método de teste | |
| GB201307256D0 (en) | Diagnostic method | |
| GB201302036D0 (en) | Diagnosis |